Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proc Natl Acad Sci U S A. 2008 Nov 11; 105(45):17493-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.